CannonCassidy

CannonCassidy was brought on board by the senior manager of marketing capabilities at Takeda Pharmaceuticals to create naming architectures that would align with the global brand. The team was also tasked with coming up with a unique and differentiated name for the ingredient complex in their product. CannonCassidy worked closely with the client, providing a list of options within a week, and made necessary adjustments based on feedback and consumer research. The engagement, which ran from 2013 to 2015, was successful and the client invested between $20,000-$30,000 in their services.

In another project, CannonCassidy was hired by a pharmaceutical company's senior director of regulatory affairs for proprietary naming. The company has been working with CannonCassidy since April 2011 and has invested around $400,000 in their services. CannonCassidy conducts a full naming assessment for new drugs, does a linguistics review, and phonetic and orthographic computer analysis. They also vet the name with healthcare professionals before submission to the FDA. The client has expressed satisfaction with CannonCassidy's services, citing them as more nimble and able to get the job done.

CannonCassidy also worked with a large pharmaceutical company in the oncology therapy space. The company was looking for a rapid, cost-effective process in creating a new trade name for a project in development. CannonCassidy took time to understand the company's objectives and key timelines and set up weekly brainstorming sessions. They also managed the legal process behind claiming the name. The project, which cost about $120,000, was completed in August 2017 and was delayed due to efforts around testing the creative concepts in Europe.